Formalin Toxoids and the Innate Danger Signal

Gaston Ramon, Alexander Glenny, and Disarming Bacterial Exotoxins

Unlike intracellular viruses or invasive septicemic bacteria that destroy organs by proliferating throughout the body, Corynebacterium diphtheriae and Clostridium tetani kill their hosts from afar while remaining confined to a small local niche. Corynebacterium diphtheriae colonizes the pharyngeal mucosa behind a leathery gray pseudomembrane of fibrin and necrotic leukocytes. The anaerobic spore-former Clostridium tetani germinates inside oxygen-starved puncture wounds. From those restricted lesions, each bacterium secretes a soluble A-B polypeptide exotoxin into the circulation. Diphtheria toxin binds heparin-binding epidermal growth factor receptors on cardiac myocytes and peripheral Schwann cells, translocates its catalytic A subunit into the cytosol, and ADP-ribosylates elongation factor 2 (EF-2). That reaction halts cellular protein synthesis and triggers fatal myocarditis or polyneuritis. Tetanus neurotoxin (TeNT) enters motor neurons, ascends to spinal inhibitory interneurons, and cleaves synaptobrevin (VAMP-2). Blocking the release of glycine and gamma-aminobutyric acid (GABA) causes opposing skeletal muscles to fire in unrelenting spastic paralysis at a lethal human dose of just 2.5 nanograms per kilogram.

In December 1890 in Robert Koch's Berlin institute, Emil von Behring and Shibasaburo Kitasato demonstrated that animals injected with sub-lethal filtrates of tetanus or diphtheria broth generated blood-borne antitoxins capable of neutralizing the poison in naive recipients. Passive serotherapy using antitoxin harvested from immunized horses cut hospital case fatality rates in half, yet equine antibodies offered only transient protection. Because the patient's own B cells had never encountered the antigen, host catabolism cleared the foreign horse immunoglobulin within two to three weeks. Repeat infusions frequently precipitated type III immune-complex serum sickness or fatal anaphylaxis against equine proteins. Attempts to induce active human immunity by injecting neutral mixtures of live toxin and equine antitoxin proved perilous whenever freezing temperatures or batch errors dissociated the complex and released free toxin.

In 1923 at the Pasteur Institute annex in Garches outside Paris, veterinarian Gaston Ramon discovered a chemical method to sever toxicity from immunogenicity permanently. Having previously developed an in vitro flocculation assay that measured the precipitating potency of diphtheria toxin against standard antitoxin in test tubes, Ramon added 0.3 to 0.4 percent formalin (aqueous formaldehyde, $\text{HCHO}$) to crude diphtheria toxin filtrate and incubated the mixture at $37^\circ\text{C}$ for four weeks. When tested in guinea pigs, the treated filtrate produced zero local necrosis or systemic paralysis. Yet it flocculated fiercely with diphtheria antitoxin in glass tubes and elicited high titers of neutralizing antibodies in vivo. Ramon termed the modified protein an anatoxine, known in English as a toxoid.

At the molecular level, formaldehyde detoxifies protein exotoxins through a two-step nucleophilic crosslinking reaction. Formaldehyde first reacts with the unprotonated $\epsilon$-amino groups of surface lysine residues to form unstable methylol adducts and Schiff bases. Those intermediates then condense with adjacent tyrosine, arginine, histidine, or tryptophan side chains to form rigid covalent methylene bridges ($-\text{CH}_2-$). These intramolecular crosslinks bolt the enzymatic active site and translocation domain of the toxin shut and prevent heat denaturation. At the same time, they preserve the three-dimensional tertiary surface loops—the conformational epitopes—that naive B-cell receptors recognize. Antibodies raised against the cross-linked toxoid bind the native bacterial toxin with high affinity and sterically block its receptor-binding domain from docking onto host cells.

While overseeing antitoxin-producing horses at Garches in 1925, Ramon observed a second immunological phenomenon. Horses that developed a sterile pyogenic abscess at the injection site consistently generated far higher antitoxin titers than horses whose injection sites healed cleanly. Highly purified soluble proteins like toxoids lack the pathogen-associated molecular patterns (PAMPs) of whole microbes. Without an innate inflammatory cue, they diffuse rapidly from subcutaneous tissue and fail to upregulate costimulatory molecules (CD80 and CD86) on dendritic cells. Ramon proved this principle by mixing diphtheria toxoid with breadcrumbs, tapioca starch, or lanolin, multiplying antibody output severalfold. In 1926 at the Wellcome Physiological Research Laboratories in London, Alexander Glenny and colleagues precipitated diphtheria toxoid onto insoluble microcrystals of aluminum potassium sulfate (alum). Adsorbed onto aluminum salts, the toxoid eluted slowly from the muscle depot while the crystals induced local cell stress. That stress released uric acid and host DNA, activating the NLRP3 inflammasome in macrophages and recruiting antigen-presenting cells to the draining lymph node. Combined with whole-cell pertussis in the 1940s and administered to pregnant women so maternal $\text{IgG}$ crosses the placenta via $\text{FcRn}$ receptors, diphtheria and tetanus toxoids reduced global neonatal tetanus mortality from roughly 787,000 deaths in 1988 to fewer than 25,000 per year within three decades.